Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7M4T

Menin bound to M-1121

7M4T の概要
エントリーDOI10.2210/pdb7m4t/pdb
分子名称Menin, methyl {(1S,2R)-2-[(1S)-2-(azetidin-1-yl)-1-(3-fluorophenyl)-1-{1-[(3-methoxy-1-{4-[(1S,4S)-5-propanoyl-2,5-diazabicyclo[2.2.1]heptane-2-sulfonyl]phenyl}azetidin-3-yl)methyl]piperidin-4-yl}ethyl]cyclopentyl}carbamate, praseodymium triacetate, ... (4 entities in total)
機能のキーワードinhibitor, transcription
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数1
化学式量合計63446.45
構造登録者
Stuckey, J. (登録日: 2021-03-22, 公開日: 2021-08-11, 最終更新日: 2024-11-13)
主引用文献Zhang, M.,Aguilar, A.,Xu, S.,Huang, L.,Chinnaswamy, K.,Sleger, T.,Wang, B.,Gross, S.,Nicolay, B.N.,Ronseaux, S.,Harvey, K.,Wang, Y.,McEachern, D.,Kirchhoff, P.D.,Liu, Z.,Stuckey, J.,Tron, A.E.,Liu, T.,Wang, S.
Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression.
J.Med.Chem., 64:10333-10349, 2021
Cited by
PubMed Abstract: Targeting the menin-MLL protein-protein interaction is being pursued as a new therapeutic strategy for the treatment of acute leukemia carrying MLL-rearrangements (MLLr leukemia). Herein, we report M-1121, a covalent and orally active inhibitor of the menin-MLL interaction capable of achieving complete and persistent tumor regression. M-1121 establishes covalent interactions with Cysteine 329 located in the MLL binding pocket of menin and potently inhibits growth of acute leukemia cell lines carrying MLL translocations with no activity in cell lines with wild-type MLL. Consistent with the mechanism of action, M-1121 drives dose-dependent down-regulation of and gene expression in the MLL-rearranged MV4;11 leukemia cell line. M-1121 is orally bioavailable and shows potent antitumor activity with tumor regressions observed at tolerated doses in the MV4;11 subcutaneous and disseminated models of MLL-rearranged leukemia. Together, our findings support development of an orally active covalent menin inhibitor as a new therapy for MLLr leukemia.
PubMed: 34196551
DOI: 10.1021/acs.jmedchem.1c00789
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.74 Å)
構造検証レポート
Validation report summary of 7m4t
検証レポート(詳細版)ダウンロードをダウンロード

246704

件を2025-12-24に公開中

PDB statisticsPDBj update infoContact PDBjnumon